Summary
WASHINGTON -- Erbitux, the drug at the center of the stock- trading scandal that brought Martha Stewart to trial, won government approval Thursday as a last-ditch treatment for advanced colorectal cancer.
Doctors believe roughly 20,000 patients a year might benefit from Erbitux, one in a new type of cancer medicines that jam chemical signals that spur tumor growth.See the full content of this document
Extract
Drug in Stewart Case Ok'd
But they caution that Erbitux is not a miracle drug. Patients have clamored for the drug since its roller-coaster attempts at Food and Dru...
See the full content of this document
Sponsored links
